Gene: ST3GAL6
Official Full Name: ST3 beta-galactoside alpha-2,3-sialyltransferase 6provided by HGNC
Gene Summary: The protein encoded by this gene is a member of the sialyltransferase family. Members of this family are enzymes that transfer sialic acid from the activated cytidine 5'-monophospho-N-acetylneuraminic acid to terminal positions on sialylated glycolipids (gangliosides) or to the N- or O-linked sugar chains of glycoproteins. This protein has high specificity for neolactotetraosylceramide and neolactohexaosylceramide as glycolipid substrates and may contribute to the formation of selectin ligands and sialyl Lewis X, a carbohydrate important for cell-to-cell recognition and a blood group antigen. [provided by RefSeq, Apr 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31906 | ST3GAL6 Knockout cell line (HCT 116) | Human | ST3GAL6 | 1:2~1:4 | Negative | Online Inquiry |
KO31907 | ST3GAL6 Knockout cell line (HEK293) | Human | ST3GAL6 | 1:3~1:6 | Negative | Online Inquiry |
KO31908 | ST3GAL6 Knockout cell line (A549) | Human | ST3GAL6 | 1:3~1:4 | Negative | Online Inquiry |
ST3GAL6 Gene Knockout Cell Lines are specifically engineered cellular models in which the ST3GAL6 gene has been inactivated, enabling researchers to investigate the functional implications of this gene in various biological contexts. The ST3GAL6 protein is a vital enzyme involved in the biosynthesis of sialylated glycans, which play critical roles in cell-cell interactions, immune responses, and pathogen recognition. By creating knockout models, scientists can elucidate the gene's role in these processes, thus enhancing our understanding of both normal physiology and the underlying mechanisms of diseases.
These cell lines operate through a mechanism wherein the removal of the ST3GAL6 gene results in the absence of its related enzymatic activity, leading to significant alterations in glycan structures on the cell surface. This modification allows for a detailed exploration of how changes in glycosylation patterns can affect various cellular processes, including adhesion, signaling pathways, and immune evasion. The availability of ST3GAL6 knockout models is particularly valuable in cancer research, infectious disease studies, and investigations of autoimmune disorders, as alterations in glycosylation are linked to tumor progression and pathogen virulence.
One key advantage of utilizing ST3GAL6 Gene Knockout Cell Lines is their specificity and reproducibility. Unlike traditional methods of gene silence, such as RNA interference, our knockout models provide a permanent and stable genetic modification, facilitating long-term studies without the variability associated with transient expression systems. Additionally, these cell lines come with comprehensive characterization data, ensuring researchers can confidently interpret their findings.
For researchers and clinicians, these knockout cell lines represent an invaluable tool in dissecting the molecular underpinnings of diseases and advancing therapeutic strategies. The insights gained from studies using these models have the potential to inform the development of targeted therapies and diagnostic tools.
As a leader in the field of biogenetics, our company is dedicated to providing high-quality, specialized genetic tools. Our expertise enables us to offer products like ST3GAL6 Gene Knockout Cell Lines that empower the scientific community to push the boundaries of knowledge and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.